Critical Analysis of Antimicrobial Stewardship Implementation and Structural Gaps
The synthesis of inpatient surveillance data demonstrates that antimicrobial resistance in public hospitals is fundamentally shaped by structural and ward-specific selective pressures. Empirical evidence from Gauteng public facilities highlights that methicillin-resistant Staphylococcus aureus acquisition rates fluctuate significantly across clinical settings, with intensive care units and pediatric cohorts bearing an acute bacteremia burden despite overall declines following the introduction of national stewardship guidelines (Gauteng Surveillance Group, 2023). This acute ward-level disparity is further corroborated in provincial bloodstream infection analyses, where multidrug-resistant ESKAPEEc isolates exhibit significantly elevated multiple antibiotic resistance index values within tertiary facilities and intensive care units compared to regional hospital wards (uMgungundlovu Resistance Study, 2025). Critically, while broader national public healthcare initiatives emphasize institutional adherence to standard treatment guidelines and centralized medicine monitoring systems (National Healthcare Review, 2017), a profound research gap persists regarding how facility-level resource constraints impede sustained bedside compliance and diagnostic integration. Scholarly debates remain divided between attributing resistance escalation primarily to empirical overprescribing practices and identifying structural deficits in rapid microbiological diagnostic turnaround times. Furthermore, significant methodological limitations characterize the current evidence base, including an overreliance on retrospective laboratory deduplication datasets, heavy geographic concentration in well-resourced metropolitan tertiary centers, and the persistent scarcity of prospective clinical outcome evaluations across lower-tier district hospitals. Addressing these critical limitations requires pragmatic, tier-stratified stewardship frameworks that actively align routine microbiological surveillance with localized prescribing governance across all public hospital networks.